CVS Stock Summary and Trading Ideas (CVS Health | NYSE:CVS)

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

CVS Health trades on the NYSE stock market under the symbol CVS.

As of December 12, 2025, CVS stock price declined to $79.42 with 5,631,671 million shares trading.

CVS has a beta of 0.57, meaning it tends to be less sensitive to market movements. CVS has a correlation of 0.06 to the broad based SPY ETF.

CVS has a market cap of $100.73 billion. This is considered a Large Cap stock.

Last quarter CVS Health reported $103 billion in Revenue and $1.60 earnings per share. This beat revenue expectation by $4 billion and exceeded earnings estimates by $.24.

In the last 3 years, CVS traded as high as $104.83 and as low as $43.56.

The top ETF exchange traded funds that CVS belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.

CVS has outperformed the market in the last year with a return of +65.6%, while the SPY ETF gained +14.0%. In the last 3 month period, CVS beat the market returning +6.8%, while SPY returned +4.0%. However, in the most recent 2 weeks CVS has underperformed the stock market by returning -1.2%, while SPY returned -0.2%.

CVS support price is $79.38 and resistance is $82.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVS shares will trade within this expected range on the day.